OncoImmunology
Volume 9, 2020 - Issue 1
Original Research
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation
Mark A. J. M. Hendriksa Department of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands
https://orcid.org/0000-0001-7276-4622View further author information
https://orcid.org/0000-0001-7276-4622View further author information, Emily M. Ploega Department of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlandshttps://orcid.org/0000-0002-0735-2020View further author information
https://orcid.org/0000-0002-0735-2020View further author information, Iris Koopmansa Department of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlandshttps://orcid.org/0000-0002-9976-6510View further author information
https://orcid.org/0000-0002-9976-6510View further author information, Isabel Britscha Department of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlandshttps://orcid.org/0000-0003-4772-9889View further author information
https://orcid.org/0000-0003-4772-9889View further author information, Xiurong Kea Department of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands;b Department of Immunotherapy and Gastrointestinal Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Chinahttps://orcid.org/0000-0002-0640-4466View further author information
https://orcid.org/0000-0002-0640-4466View further author information, Douwe F. Samploniusa Department of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlandshttps://orcid.org/0000-0002-0613-7150View further author information
https://orcid.org/0000-0002-0613-7150View further author information & Wijnand Helfricha Department of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-7004-3995View further author information
https://orcid.org/0000-0001-7004-3995View further author information show all